InvestorsHub Logo

Steve43

08/07/18 5:14 PM

#148070 RE: markjohn62 #148067

Amazing, cause we've been there for years, with OTC. New hands in the mix, should bring much needed, assistance in that area. New Partners will be looking for revenue to be derived from an alliance, they won't let product sit on a shelf. A welcome change for sure. Time will tell. I'm more interested in the deals and their, structure, that effects shareholder value. It will be interesting for sure. I feel confident that B. Braun's use of the product will have an immediate validation and education of the products effectiveness, surely to be observed by other Doctors. Just my opinion. Have a great evening.

shadolane

08/07/18 5:38 PM

#148072 RE: markjohn62 #148067

Seems like BIEL is always the next step away from success. The story is old.

At least B Braun will have internally driven sales since they have adopted actipatch as a user. NHS merely approved coverage. They are not a user. For fooled a bit into correlating approval of coverage to sales.

Oh well, just wait until next quarter.